Rainbow Children's Medicare Q1 FY27: Profit up 13%

Key takeaway from the quarter

Rainbow Children’s Medicare reported a rise in consolidated profitability for Q1 FY27, supported by a sharp increase in revenue from operations and higher operating profit. Net profit for the quarter was reported at ₹605.7 million, compared with ₹535.0 million in the year-ago period. Revenue from operations grew to ₹4,699.9 million from ₹3,529.3 million a year earlier. EBITDA increased to ₹1,346.5 million from ₹1,036.2 million, while the EBITDA margin moderated to 28.7% from 29.4%. Some figures in the source alert are flagged as “claimed” and “not independently verified”, but the numbers cited below are the ones stated in the provided results text.

Profit growth, but sequential comparison looks softer

On a year-on-year basis, the hospital chain’s Q1 FY27 net profit rose 13.2% to ₹605.7 million. The same period last year (Q1 FY26) net profit was ₹535.0 million. The provided context also points to a sequential decline versus Q4 FY26, when consolidated profit after tax (PAT) was stated at ₹770.4 million. That quarter-on-quarter comparison was described as “unverified” in the source note. The seasonal pattern referenced in the alert suggests pediatric healthcare can see pre-monsoon softness, which can affect sequential performance comparisons.

Revenue rises 33% as network scales up

Revenue from operations in Q1 FY27 was reported at ₹4,699.9 million, up 33.2% from ₹3,529.3 million in Q1 FY26. The strong growth in the top line was attributed in the text to higher patient volumes, better occupancy, and expansion across the healthcare network. While the prompt does not provide a location-wise breakup for Q1 FY27, it frames the growth as operating-led rather than one-off. The same dataset also includes a quarterly “Total Revenue” line of ₹3,529.3 million for Jun 2025 (Q1 FY26), aligning with the reported base. Readers should note that multiple tables are presented in the source dump, and not all lines are labelled consistently across sections.

EBITDA up 30%, margin slightly lower

EBITDA for Q1 FY27 was reported at ₹1,346.5 million, up from ₹1,036.2 million a year earlier. Despite that expansion, EBITDA margin eased to 28.7% from 29.4% in Q1 FY26, indicating that costs rose at a pace slightly faster than operating profitability. The prompt also includes a detailed expense table (QoQ comparison) that shows “Total Operating Expense” at ₹2,834.9 million for Jun 2025, and “Selling/ General/ Admin Expenses Total” at ₹1,433.8 million. However, those lines are part of a separate presentation format and should be read alongside the company’s headline revenue and EBITDA numbers. What is consistent across the narrative is that operating profit grew strongly, but the margin narrowed modestly.

Stock reaction: gains on NSE close, mixed live snapshot

Following the quarterly results announcement, shares of Rainbow Children’s Medicare ended 2.16% higher at ₹1,529 on the National Stock Exchange, as stated in the prompt. A separate market snapshot for BSE shows a price of ₹1,431.50 at 12:54 PM, down ₹10.60 (0.74%), alongside an intraday high of ₹1,462.45 and low of ₹1,424.20. These different price points likely reflect different timestamps and exchanges in the provided data. The key takeaway is that the immediate reaction mentioned for the NSE close was positive after results, while the live BSE datapoint in the feed was lower at that moment.

Board meeting and earnings call schedule

The company scheduled a board meeting on July 30, 2026 to consider and approve the audited financial results for the quarter ended June 30, 2026, according to the provided text. It also announced an earnings conference call for July 31, 2026 at 10:00 AM IST to discuss Q1 FY27 financial results and outlook. The prompt lists IIFL Capital Markets as the investor contact point for the call, along with specific representative names and phone numbers. For investors, the call timing is the next confirmed event in the immediate calendar after the results.

Context from the previous quarter (Q4 FY26)

For Q4 FY26, the prompt states consolidated revenue of ₹4,599.0 million and PAT of ₹770.4 million. Another section in the provided text also lists “Revenue from operations” at ₹4,599.01 million for Q4 FY26 and “Profit after tax” at ₹782.18 million, indicating minor variation depending on the table source included in the dump. The same FY26 summary in the prompt states revenue of ₹17,030.77 million and PAT of ₹2,815.44 million. These historical numbers help contextualise the Q1 FY27 outcome as a period where growth continued on the year-on-year view, even as the quarter-on-quarter comparison is described as softer.

Summary table of reported quarter metrics

What investors may track next

The Q1 FY27 print shows a clear acceleration in revenue growth and a parallel rise in EBITDA, but with a small moderation in margin. With the earnings call scheduled for July 31, 2026, investors are likely to look for management commentary around the drivers behind the 33.2% revenue growth, the reasons for margin softness, and how the company is pacing expansion. The board meeting and the call are the next confirmed milestones in the near term. Any further clarity on quarter-on-quarter seasonality and cost structure would typically emerge through the company’s prepared remarks and Q&A during the scheduled call.